Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2222
https://www.valueinhealthjournal.com/article/S1098-3015(14)04152-7/fulltext
Section Title : Disease-Specific Studies
Section Order : 1681
First Page : A625
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04152-7&doi=10.1016/j.jval.2014.08.2222
HEOR Topics :
Tags :
Regions :